Benzinga | Jan 29, 2021 04:52AM EST

Cantor Fitzgerald Downgrades CV Sciences to Neutral, Lowers Price Target to $0.65

Cantor Fitzgerald analyst Pablo Zuanic downgrades CV Sciences (OTC:CVSI) from Overweight to Neutral and lowers the price target from $1.35 to $0.65.